ASML's High-Stakes Balancing Act: A Record Backlog and a Political Storm Collide on July 15
Veröffentlicht: 11.07.2026 um 18:54 Uhr, Redaktion boerse-global.de
ASML’s stock has spent the past week whipsawing between analyst euphoria and geopolitical dread, a fitting prelude to the quarterly earnings report due on July 15 that will test which narrative wins out. The Dutch chip-equipment giant closed Friday at €1,574.20, down 0.51% on the day and 3.30% lower on the week — a mild pullback that barely registers against a 12-month gain of 128.94% and a year-to-date advance of 59.28%.
The short-term retrenchment has been anything but quiet. On July 7, disappointing preliminary figures from Samsung Electronics triggered a sector-wide sell-off, followed by fresh anxiety over tightening export controls. The Dutch government joined a US-led alliance that is pushing to extend restrictions beyond ASML’s extreme ultraviolet (EUV) lithography systems to include deep ultraviolet (DUV) immersion tools and even service contracts. That would put roughly one-fifth of ASML’s planned China system revenue at risk.
Then, just 48 hours later, the mood flipped. Global memory-chip makers confirmed their capital expenditure budgets for ASML systems through 2027, prompting a fresh wave of analyst upgrades. Bernstein’s David Dai lifted his price target by 33% to $2,623, citing additional sales from AI-driven demand. Morgan Stanley raised its target to €1,830 on July 7, and J.P. Morgan chimed in with its own buy recommendation. The consensus on Wall Street is a clean “Strong Buy” based on eight buy ratings in the past three months.
Yet for all the bullishness, a separate political development is casting a longer shadow. The so-called MATCH Act, introduced in the US House on April 2 by Representative Michael Baumgartner and advanced through committee on April 22, seeks to dramatically expand export curbs on ASML’s DUV immersion machines — technology that China is still allowed to buy and service. A companion Senate bill is under discussion but nothing has been enacted. ASML’s management has already factored in some headroom: the 2026 revenue guidance range of €36 billion to €40 billion, as CEO Christophe Fouquet stated, already accounts for “possible outcomes of the ongoing discussions around export controls.”
Should investors sell immediately? Or is it worth buying Asml?
The real question is whether that buffer is enough. China’s share of net system revenue tumbled to 19% in the first quarter of 2026, down from 36% in the prior quarter, while South Korea’s share surged to 45%. ASML expects China to settle at roughly 20% for the full year. That shift suggests the company is already diversifying away from its most geopolitically exposed market. The structural bull case rests on a backlog that stood at €38.8 billion at the end of 2025, stretching out to 2027 and beyond. Full-year 2025 revenue hit €32.7 billion, up 15.6%, with net profit of €9.6 billion and a gross margin of 52.8%.
Even so, the valuation is a nagging concern. ASML trades well above its historical multiples, leaving little margin for error. Some observers note the stock is acutely sensitive to any wobble in AI capital expenditure plans or macroeconomic surprises. Adding a technical wrinkle, leading chipmakers including TSMC are reportedly delaying the adoption of ASML’s newest High-NA EUV generation, preferring cheaper alternatives to immediate upgrades. The company’s capacity targets are ambitious: at least 60 Low-NA EUV systems this year, climbing to a minimum of 80 in 2027, up from 44 delivered in 2025. But those are intentions, not contracts, and supply-chain bottlenecks or demand corrections could slow the ramp.
The numbers underscore the tension. At €1,574.20, the stock sits 9.94% below its 52-week high of €1,748.00 reached on June 30, yet still well above both its 50-day moving average of €1,477.77 and its 200-day moving average of €1,166.58 — a 34.94% premium that testifies to a robust long-term uptrend. The 14-day relative strength index sits at a neutral 51.1, offering no directional signal. With an annualized 30-day volatility of 64.27%, the swings around next week’s earnings could be violent in either direction.
Asml at a turning point? This analysis reveals what investors need to know now.
For the bulls, the July 15 report must confirm that the order book for 2027 is intact across both EUV and DUV lines, and that the revenue guidance range is conservative enough to absorb any escalation in export restrictions. For the bears, the risk is that the MATCH Act moves toward passage in its current form, threatening not just new equipment sales but also the high-margin service and upgrade revenue from ASML’s installed base in China. That recurring stream is exactly the part of the business most vulnerable to a tightened regulatory regime. As CFO Roger Dassen said on the first-quarter call, the company can “absorb within the range of €36 billion to €40 billion” the effects of the export-control debate — but the lower end of that range is not far away.
The next two weeks will determine whether the political storm is a manageable headwind or a serious drag on a machine that has delivered 129% gains in a year. For now, the backlog is a fortress, but the siege is only just beginning.
Ad
Asml Stock: New Analysis - 11 July
Fresh Asml information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer zu unseren Artikeln: Keine Anlageberatung, keine Kauf oder Verkaufsempfehlung. Angaben zu Kursen, Unternehmen und Märkten ohne Gewähr; Änderungen jederzeit möglich. Börsengeschäfte können zu hohen Verlusten führen. Unsere Beiträge werden ganz oder teilweise automatisiert mit Unterstützung von AI erstellt und geprüft.
